SLU-PP-332 (5 mg vial)
Twice daily subcutaneous protocol for metabolic and weight-management research.
SLU-PP-332 is an experimental pan-agonist of the estrogen-related receptors, the class researchers call exercise mimetics because it switches muscle toward an endurance phenotype in rodents. There is no human data. The protocol below splits small doses morning and afternoon per community convention.
Quick answer: at the standard 5 mg + 0.5 mL reconstitution, a 1250 mcg x2 daily dose of SLU-PP-332 draws 12.5 units (0.125 mL) x2 on a U-100 insulin syringe, twice daily subcutaneous.
Protocol overview
Dosing & reconstitution
Frequency: Twice daily subcutaneous
Typical duration: 8 weeks
Reconstitution: 5 mg vial + 0.5 mL bacteriostatic water = 10 mg/mL. Units below are for a U-100 insulin syringe at this concentration.
| Phase | Dose | Units per injection |
|---|---|---|
| Weeks 1-2 | 625 mcg x2 daily | 6.25 units (0.0625 mL) x2 |
| Weeks 3-8 | 1250 mcg x2 daily | 12.5 units (0.125 mL) x2 |
Units = (dose ÷ concentration) × 100 on a U-100 syringe. Change the vial size or water volume and the calculator redoes all of this for you.
Track this protocol → Free account · log doses, rotate sites, never lose your history
SLU-PP-332 dosing — what the literature actually supports
We publish a schedule when there is a citable human source and we say so when there is not. Filling this space with a number nobody measured would make the page look more complete and be worth less than nothing to you.
Reconstitution and measurement
This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for SLU-PP-332: Not stocked by our featured supplier.
- Wipe the stoppers of both vials with an alcohol swab and let them dry.
- Draw the bacteriostatic water with a sterile syringe and inject it slowly down the inside wall of the peptide vial — never straight onto the powder.
- Swirl gently until the solution is clear. Do not shake; foaming and agitation damage peptides.
- Label the vial with the date and concentration, and refrigerate at 2–8 °C protected from light.
Storage and stability
Important notes
Practical considerations for consistency and safety.
- Use a new sterile insulin syringe for each injection and dispose in a proper sharps container.
- Inject slowly and steadily; wait a few seconds before withdrawing the needle to ensure complete delivery.
- Administer at the same time each day for consistent levels. Setting a daily reminder helps maintain the schedule.
- This compound lacks controlled human safety data. Start with the lowest reported amount and increase gradually while monitoring for any adverse reactions.
- The 5 mg vial size is standard for this compound. Reconstitute with 0.5 mL bacteriostatic water for a convenient concentration.
How SLU-PP-332 works
A pan-agonist of the estrogen-related receptors (ERRα/β/γ), studied as an "exercise mimetic" for its effects on oxidative metabolism and mitochondrial function in muscle.
Benefits & side effects
Potential benefits
- Exercise mimetic activating ERR pathways
- May enhance endurance and fat oxidation
- Preclinical results show improved metabolic markers
- Does not replace exercise but may augment it
Possible side effects
- Very limited human safety data
- Injection site reactions
- Potential for metabolic changes
- Novel compound with limited track record
This list reflects published literature and community reports. Individual responses vary. Not medical advice.
Bloodwork worth tracking
The community-standard practice is a baseline panel before starting, a recheck 8 to 12 weeks in, and another after time off. For SLU-PP-332, the markers most worth watching:
CMPCBClipid panel
Typical time off: 4 wks
Lab panels are how a research protocol stays honest: numbers move before symptoms do. Interpretation belongs with a clinician. Not medical advice.
Lifestyle factors
None of the literature above was run on a background of poor sleep and no protein. These variables move outcomes more reliably than any compound on this site.
- Protein in the 1.6 to 2.2 g/kg range preserves lean mass through any body-composition phase.
- Resistance training 2 to 4 days per week plus 150+ minutes of weekly aerobic work reinforces whatever the protocol is doing.
- Sleep is the recovery window: 7 to 9 hours at consistent times.
- Hydration matters more than usual on compounds with GI or flushing effects: 2 to 3 liters daily.
- Track the variables that matter: weigh-ins, measurements, photos, and labs at sensible intervals.
Quick answers
How many syringe units is a 1250 mcg x2 daily dose of SLU-PP-332?
At the standard reconstitution of 5 mg with 0.5 mL bacteriostatic water (10 mg/mL), a 1250 mcg x2 daily dose draws 12.5 units (0.125 mL) x2 on a U-100 insulin syringe.
How do you reconstitute SLU-PP-332?
Add 0.5 mL of bacteriostatic water to the 5 mg vial for 10 mg/mL. Inject the water slowly down the inside wall of the vial, swirl gently without shaking, and refrigerate at 2 to 8 °C after mixing.
How long does a 5 mg vial of SLU-PP-332 last?
About 4 maintenance doses of 1250 mcg x2 daily, roughly 0.3 weeks at twice daily subcutaneous.
Does SLU-PP-332 have human trial data?
No. The evidence base is animal and cell studies; the practical dosing shown is community convention, and the page labels it that way.
How does SLU-PP-332 work?
A pan-agonist of the estrogen-related receptors (ERRα/β/γ), studied as an "exercise mimetic" for its effects on oxidative metabolism and mitochondrial function in muscle.
Sourcing SLU-PP-332
Our featured supplier does not stock this compound, and we are not going to point you at a vendor we have not looked at. Use the COA checklist on whoever you do buy from, and check the batch number on the certificate against the vial you receive.
